biocardia.com (BCDA) - Volume dodolan perusahaan

The scientific determination of BioCardia, Inc. (BCDA) management in developing cell therapy defines the business's strategic direction. The company's sales performance reflects this process, where the current parameter equals 0.00. The issuer's success is based on the safety of the CardiAMP system, while financial flexibility is maintained by delegating trials to international CROs, thereby minimizing operational risks.

Pendapatan lan volume dodolan BioCardia, Inc (BCDA): kanggo periode 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis BioCardia (BCDA)

- rega saham lan prakiraan rega para ahli:

Bagan owah-owahan rega BioCardia Inc|BCDA - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar BioCardia, Inc.|BCDA - Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Saham BioCardia|BCDA - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku biocardia.com|BCDA - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Kabeh Utang marang Dana Pribadi BioCardia, Inc.|BCDA - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal BioCardia Inc.|BCDA - Utang perusahaan|Rasio utang marang nilai buku BioCardia, Inc.|BCDA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan BioCardia|Koefisien jangkoan perantara biocardia.com

- rincian bathi lan kelipatan pasar:

BCDA - Bathi resik|Bathi sing dikarepake BioCardia, Inc.|BCDA - Pangali P/E|Prakiraan rega marang bathi biocardia.com|BCDA - Pangali PEG|Nilai perusahaan marang bathi operasional sadurunge panyusutan BioCardia, Inc.|BCDA - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) BioCardia|BCDA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan biocardia.com|BCDA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep BioCardia, Inc.

- statistik dodolan lan pendapatan perusahaan:

BCDA - Pendapatan lan volume dodolan|Prakiraan volume dodolan BioCardia Inc|BCDA - Rasio rega marang pendapatan|Rega forward marang dodolan BioCardia, Inc.

Analisis komprehensif perusahaan:BioCardia Inc BCDA

BioCardia, Inc. (BCDA) implementation of ESG principles and bioethics in cell therapy requires stable funding, making the company's sales profile a key indicator of operational resilience. This metric captures actual cash inflows from sales, excluding accounting adjustments, allowing investors to distinguish systemic business growth from artificial revenue inflation occurring alongside declining margins and frozen capital.

Pesaing wigati